Alpha Glycerylphosphoryl Choline 50% 99% Alpha GPC

Product Details
Customization: Available
Powder: Yes
Customized: Non-Customized
Still deciding? Get samples of US$ 300/kg
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
10000000 RMB
Plant Area
101~500 square meters
  • Alpha Glycerylphosphoryl Choline 50% 99% Alpha GPC
  • Alpha Glycerylphosphoryl Choline 50% 99% Alpha GPC
  • Alpha Glycerylphosphoryl Choline 50% 99% Alpha GPC
  • Alpha Glycerylphosphoryl Choline 50% 99% Alpha GPC
  • Alpha Glycerylphosphoryl Choline 50% 99% Alpha GPC
  • Alpha Glycerylphosphoryl Choline 50% 99% Alpha GPC
Find Similar Products

Basic Info.

Model NO.
HNB-141
Certification
GMP, HSE, USP, BP
Suitable for
Elderly, Children, Adult
State
Powder
Purity
>99%
Transport Package
Aluminium Foil Bag, Cardboard Drum
Trademark
HNB-Biotech
Origin
Shaanxi, China
Production Capacity
5000kg/Month

Product Description

Alpha Glycerylphosphoryl Choline 50% 99% Alpha GPC
Alpha Glycerylphosphoryl Choline 50% 99% Alpha GPC
Alpha Glycerylphosphoryl Choline 50% 99% Alpha GPC
Product name Alpha Gpc/Choline glycerophosphate
Cas No. 28319-77-9
Molecular Formula C42H61KO16
Appearance White powder

L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain and in milk. It is also a parasympathomimetic acetylcholine precursor which may have potential for the treatment of Alzheimer's disease and dementia.IC50 value:Target: Anti-ADAlpha-GPC rapidly delivers choline to the brain across the blood-brain barrier and is a biosynthetic precursor of the acetylcholine neurotransmitter. It is a non-prescription drug in most countries due to its Generally Recognised As Safe (GRAS) status. Studies have investigated its efficacy for cognitive disorders including stroke and Alzheimer's disease. An Italian multicentre clinical trial on 2,044 patients suffering from recent stroke were supplied alpha-GPC in doses of 1,000 mg/day for 28 days and 400 mg three times per day for the five ensuing months. The trial confirmed the therapeutic role of alpha-GPC on the cognitive recovery of patients based on four measurement scales, three of which reached statistical significance.
Alpha Glycerylphosphoryl Choline 50% 99% Alpha GPCAlpha Glycerylphosphoryl Choline 50% 99% Alpha GPCAlpha Glycerylphosphoryl Choline 50% 99% Alpha GPCAlpha Glycerylphosphoryl Choline 50% 99% Alpha GPCAlpha Glycerylphosphoryl Choline 50% 99% Alpha GPCAlpha Glycerylphosphoryl Choline 50% 99% Alpha GPCAlpha Glycerylphosphoryl Choline 50% 99% Alpha GPC
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier